GVK BIO and Aragen Bioscience Sign Definitive Agreement to Acquire Aragen Bioscience, Inc.
The acquisition of Aragen Bioscience provides GVK BIO with world-class expertise in large molecule R&D services and a unique and extensive set of high-content biological services. Combined with GVK BIO’s established small molecule discovery and development capabilities, the acquisition of Aragen Bioscience uniquely positions GVK BIO as a leading provider of integrated R&D services across both large and small molecule platforms and provides a base for further expansion. <MORE
BioProcessing Summit 2015
Booth # 407
We are excited for this year’s BioProcessing Summit in Boston. Discover how Aragen Bioscience can transform the way you do research by visiting us at Booth 407 for a discussion with our team about our newest service offerings.